\-\ Texto\\:\\ \ \(0\)\
\-\ elevated\\ creatinine\ \(1\)\
\-\ a\\ biopsy\\ is\\ being\\ planned\\ and\\ the\\ patient\\ will\\ then\\ likely\\ be\\ further\\ evaluated\\ by\\ surgery\\.\ \(0\)\
\-\ large\\ retroperitoneal\\ mass\\ which\\ predominately\\ involves\\ the\\ inferior\\ vena\\ cava\\ at\\ the\\ level\\ of\\ the\\ renal\\ vein\\ drainage\\.\\ \\ there\\ are\\ multiple\\ punctate\\ calcifications\\ centrally\\.\\ \\ it\\ appears\\ to\\ be\\ extending\\ into\\ the\\ right\\ psoas\\ muscle\\ and\\ demonstrates\\ mass\\ effect\\ on\\ the\\ right\\ kidney\\ and\\ proximal\\ ureter\\.\ \(0\)\
\-\ angiosarcoma\ \(17\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ angiosarcoma\ \(17\)\
\-\ malignant\\ fibrous\\ histiocytoma\ \(11\)\
\-\ paragangliomas\ \(10\)\
\-\ teratomas\ \(30\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 66\\ yo\\ female\\ status\\ post\\ placement\\ of\\ a\\ right\\ ureteral\\ stent\\ to\\ treat\\ right\\ hydronephrosis\\ and\\ hydroureter\\ secondary\\ to\\ extrinsic\\ compression\\ by\\ a\\ retroperitoneal\\ mass\ \(1\)\
\-\ this\\ is\\ an\\ interesting\\ case\\ of\\ a\\ large\\ mass\\ predominately\\ involving\\ the\\ ivc\\.\\ \\ statistically\\ this\\ is\\ likely\\ an\\ mfh\\,\\ with\\ a\\ liposarcoma\\ an\\ leiomyosarcoma\\ less\\ likely\\,\\ given\\ the\\ absence\\ of\\ fat\\.\\ \\ angiosarcoma\\,\\ while\\ extremely\\ rare\\,\\ is\\ an\\ interesting\\ possibility\\.\\ \\ the\\ patient\\ was\\ just\\ diagnosed\\ with\\ the\\ mass\\ and\\ is\\ awaiting\\ biopsy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.3449540037292967\ \(0\)\
\-\ predominately\\:\\ 0\\.2190069373837483\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.2190069373837483\ \(0\)\
\-\ interesting\\:\\ 0\\.20484791407619873\ \(0\)\
\-\ the\\:\\ 0\\.19328887233322647\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.18673542228193785\ \(0\)\
\-\ mass\\:\\ 0\\.1850069724509858\ \(0\)\
\-\ likely\\:\\ 0\\.17365966529220758\ \(0\)\
\-\ an\\:\\ 0\\.14816961156684955\ \(0\)\
\-\ statistically\\:\\ 0\\.13625855097359635\ \(0\)\
\-\ mfh\\:\\ 0\\.13625855097359635\ \(0\)\
\-\ biopsy\\:\\ 0\\.13580351236472765\ \(0\)\
\-\ paragangliomas\\:\\ 0\\.13364083028793958\ \(0\)\
\-\ is\\:\\ 0\\.1326412493002815\ \(0\)\
\-\ right\\:\\ 0\\.12846440401868128\ \(0\)\
\-\ hydroureter\\:\\ 0\\.12187010235608915\ \(0\)\
\-\ teratomas\\:\\ 0\\.11668424224865445\ \(0\)\
\-\ awaiting\\:\\ 0\\.1141946849699498\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.11202387351914295\ \(0\)\
\-\ psoas\\:\\ 0\\.11071695414909875\ \(0\)\
\-\ extrinsic\\:\\ 0\\.1044724097549947\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.10362315425652147\ \(0\)\
\-\ punctate\\:\\ 0\\.10094636717804506\ \(0\)\
\-\ ureteral\\:\\ 0\\.10094636717804506\ \(0\)\
\-\ and\\:\\ 0\\.10008402510669283\ \(0\)\
\-\ planned\\:\\ 0\\.09926364799767634\ \(0\)\
\-\ extremely\\:\\ 0\\.09926364799767634\ \(0\)\
\-\ creatinine\\:\\ 0\\.0986346290195613\ \(0\)\
\-\ treat\\:\\ 0\\.09802807987048044\ \(0\)\
\-\ stent\\:\\ 0\\.09773274076002371\ \(0\)\
\-\ large\\:\\ 0\\.09707241397071596\ \(0\)\
\-\ centrally\\:\\ 0\\.09553852259177577\ \(0\)\
\-\ ureter\\:\\ 0\\.09503157238401386\ \(0\)\
\-\ ivc\\:\\ 0\\.09406093273172147\ \(0\)\
\-\ vena\\:\\ 0\\.09359565511128946\ \(0\)\
\-\ cava\\:\\ 0\\.0931427863849536\ \(0\)\
\-\ 66\\:\\ 0\\.09084730631370012\ \(0\)\
\-\ possibility\\:\\ 0\\.09008396113748748\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.08989836835230369\ \(0\)\
\-\ involves\\:\\ 0\\.08429034576066781\ \(0\)\
\-\ evaluated\\:\\ 0\\.08276859054199978\ \(0\)\
\-\ by\\:\\ 0\\.08227244097290383\ \(0\)\
\-\ be\\:\\ 0\\.07859180901865187\ \(0\)\
\-\ drainage\\:\\ 0\\.0775827304345651\ \(0\)\
\-\ just\\:\\ 0\\.07749358812585173\ \(0\)\
\-\ absence\\:\\ 0\\.07722893491246\ \(0\)\
\-\ of\\:\\ 0\\.07582738411604843\ \(0\)\
\-\ placement\\:\\ 0\\.0756422787120763\ \(0\)\
\-\ fibrous\\:\\ 0\\.07524825707220635\ \(0\)\
\-\ rare\\:\\ 0\\.07312737309820236\ \(0\)\
\-\ to\\:\\ 0\\.072651223201546\ \(0\)\
\-\ appears\\:\\ 0\\.07093732218661704\ \(0\)\
\-\ compression\\:\\ 0\\.07093732218661704\ \(0\)\
\-\ calcifications\\:\\ 0\\.0706972959882415\ \(0\)\
\-\ diagnosed\\:\\ 0\\.0701693289822339\ \(0\)\
\-\ vein\\:\\ 0\\.06943457071162457\ \(0\)\
\-\ malignant\\:\\ 0\\.06905171715053599\ \(0\)\
\-\ muscle\\:\\ 0\\.06878344031005357\ \(0\)\
\-\ then\\:\\ 0\\.06857182921274836\ \(0\)\
\-\ kidney\\:\\ 0\\.06805405828679185\ \(0\)\
\-\ effect\\:\\ 0\\.0679523719301646\ \(0\)\
\-\ involving\\:\\ 0\\.06785129085305464\ \(0\)\
\-\ status\\:\\ 0\\.06760118956045598\ \(0\)\
\-\ being\\:\\ 0\\.06750217137428201\ \(0\)\
\-\ given\\:\\ 0\\.06663606788410652\ \(0\)\
\-\ this\\:\\ 0\\.06657190609143895\ \(0\)\
\-\ elevated\\:\\ 0\\.06603692725872999\ \(0\)\
\-\ inferior\\:\\ 0\\.06590161522156708\ \(0\)\
\-\ less\\:\\ 0\\.06590161522156708\ \(0\)\
\-\ extending\\:\\ 0\\.06567846390514555\ \(0\)\
\-\ further\\:\\ 0\\.06309244300620921\ \(0\)\
\-\ patient\\:\\ 0\\.06301328373087757\ \(0\)\
\-\ while\\:\\ 0\\.06260454111319265\ \(0\)\
\-\ will\\:\\ 0\\.062347517837617085\ \(0\)\
\-\ proximal\\:\\ 0\\.06051829276347953\ \(0\)\
\-\ yo\\:\\ 0\\.06051829276347953\ \(0\)\
\-\ renal\\:\\ 0\\.06032310014528769\ \(0\)\
\-\ fat\\:\\ 0\\.06025853135717357\ \(0\)\
\-\ level\\:\\ 0\\.058514516659606726\ \(0\)\
\-\ secondary\\:\\ 0\\.057416733912845776\ \(0\)\
\-\ metastatic\\:\\ 0\\.05312783291198207\ \(0\)\
\-\ post\\:\\ 0\\.05270954647352239\ \(0\)\
\-\ surgery\\:\\ 0\\.05208090311493013\ \(0\)\
\-\ into\\:\\ 0\\.0514939240288395\ \(0\)\
\-\ it\\:\\ 0\\.049585917234501495\ \(0\)\
\-\ demonstrates\\:\\ 0\\.048665961739400264\ \(0\)\
\-\ case\\:\\ 0\\.048665961739400264\ \(0\)\
\-\ multiple\\:\\ 0\\.04738076488055597\ \(0\)\
\-\ female\\:\\ 0\\.046743788727756294\ \(0\)\
\-\ which\\:\\ 0\\.04404732480265897\ \(0\)\
\-\ disease\\:\\ 0\\.040662189551582566\ \(0\)\
\-\ there\\:\\ 0\\.038543897835165195\ \(0\)\
\-\ with\\:\\ 0\\.03793634547999455\ \(0\)\
\-\ are\\:\\ 0\\.03675740220635651\ \(0\)\
\-\ at\\:\\ 0\\.03658866980934269\ \(0\)\
\-\ was\\:\\ 0\\.03375982601322295\ \(0\)\
\-\ on\\:\\ 0\\.029256118464767798\ \(0\)\
